206 related articles for article (PubMed ID: 2786779)
1. Anti-neutrophil nuclear antibody in ulcerative colitis, Crohn's disease and primary sclerosing cholangitis.
Snook JA; Chapman RW; Fleming K; Jewell DP
Clin Exp Immunol; 1989 Apr; 76(1):30-3. PubMed ID: 2786779
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of antibodies against neutrophils in patients with inflammatory bowel disease and primary sclerosing cholangitis.
Seibold F; Weber P; Klein R; Berg PA; Wiedmann KH
Gut; 1992 May; 33(5):657-62. PubMed ID: 1612483
[TBL] [Abstract][Full Text] [Related]
3. Neutrophil autoantibodies: a genetic marker in primary sclerosing cholangitis and ulcerative colitis.
Seibold F; Slametschka D; Gregor M; Weber P
Gastroenterology; 1994 Aug; 107(2):532-6. PubMed ID: 8039629
[TBL] [Abstract][Full Text] [Related]
4. Anti-lactoferrin antibodies and other types of ANCA in ulcerative colitis, primary sclerosing cholangitis, and Crohn's disease.
Peen E; Almer S; Bodemar G; Rydén BO; Sjölin C; Tejle K; Skogh T
Gut; 1993 Jan; 34(1):56-62. PubMed ID: 8432453
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of anti-neutrophil antibody in primary sclerosing cholangitis and ulcerative colitis using an alkaline phosphatase technique.
Lo SK; Fleming KA; Chapman RW
Gut; 1992 Oct; 33(10):1370-5. PubMed ID: 1446862
[TBL] [Abstract][Full Text] [Related]
6. Antigen specificity of circulating anti-neutrophil cytoplasmic antibodies in inflammatory bowel disease.
Kossa K; Coulthart A; Ives CT; Pusey CD; Hodgson HJ
Eur J Gastroenterol Hepatol; 1995 Aug; 7(8):783-9. PubMed ID: 7496870
[TBL] [Abstract][Full Text] [Related]
7. Neutrophil cytoplasmic antibodies: a link between primary sclerosing cholangitis and ulcerative colitis.
Duerr RH; Targan SR; Landers CJ; LaRusso NF; Lindsay KL; Wiesner RH; Shanahan F
Gastroenterology; 1991 May; 100(5 Pt 1):1385-91. PubMed ID: 2013383
[TBL] [Abstract][Full Text] [Related]
8. Contrasting Pattern of Chronic Inflammatory Bowel Disease in Primary and Autoimmune Sclerosing Cholangitis.
Bjarnason I; Hayee B; Pavlidis P; Kvasnovsky C; Scalori A; Sisson G; Charlesworth A; Shaikh H; Bjornsson E; Heneghan MA
EBioMedicine; 2015 Oct; 2(10):1523-7. PubMed ID: 26629548
[TBL] [Abstract][Full Text] [Related]
9. Antineutrophil cytoplasmic antibodies (ANCA) directed against cathepsin G in ulcerative colitis, Crohn's disease and primary sclerosing cholangitis.
Halbwachs-Mecarelli L; Nusbaum P; Noël LH; Reumaux D; Erlinger S; Grünfeld JP; Lesavre P
Clin Exp Immunol; 1992 Oct; 90(1):79-84. PubMed ID: 1327593
[TBL] [Abstract][Full Text] [Related]
10. Antineutrophil cytoplasmic autoantibodies in autoimmune liver and inflammatory bowel diseases.
Claise C; Johanet C; Bouhnik Y; Kapel N; Homberg JC; Poupon R
Liver; 1996 Feb; 16(1):28-34. PubMed ID: 8868075
[TBL] [Abstract][Full Text] [Related]
11. Serum autoantibodies, ulcerative colitis and primary sclerosing cholangitis.
Chapman RW; Cottone M; Selby WS; Shepherd HA; Sherlock S; Jewell DP
Gut; 1986 Jan; 27(1):86-91. PubMed ID: 3485067
[TBL] [Abstract][Full Text] [Related]
12. Mucosal IgG4 cell infiltration in ulcerative colitis is linked to disease activity and primary sclerosing cholangitis.
Raina A; Yadav D; Regueiro M; Krasinskas AM; Saul MI; Sapienza DA; Binion DG; Hartman DJ
Inflamm Bowel Dis; 2013 May; 19(6):1232-7. PubMed ID: 23619716
[TBL] [Abstract][Full Text] [Related]
13. Risk for colorectal neoplasia in patients with colonic Crohn's disease and concomitant primary sclerosing cholangitis.
Braden B; Halliday J; Aryasingha S; Sharifi Y; Checchin D; Warren BF; Kitiyakara T; Travis SP; Chapman RW
Clin Gastroenterol Hepatol; 2012 Mar; 10(3):303-8. PubMed ID: 22037429
[TBL] [Abstract][Full Text] [Related]
14. Anti-neutrophil antibodies in primary sclerosing cholangitis.
Terjung B; Worman HJ
Best Pract Res Clin Gastroenterol; 2001 Aug; 15(4):629-42. PubMed ID: 11492972
[TBL] [Abstract][Full Text] [Related]
15. Significance and specificity of antibodies to neutrophils detected by western blotting for the serological diagnosis of primary sclerosing cholangitis.
Klein R; Eisenburg J; Weber P; Seibold F; Berg PA
Hepatology; 1991 Dec; 14(6):1147-52. PubMed ID: 1720413
[TBL] [Abstract][Full Text] [Related]
16. Anti-neutrophil cytoplasmic antibodies in inflammatory bowel disease: do they recognize different subsets of a heterogeneous disease?
Castellino F; Rosina F; Bansi DS; Bauducci M; Touscoz GA; Giorda L; Borghesio E; Bessone MP; Astegiano M; Musso A
Eur J Gastroenterol Hepatol; 1995 Sep; 7(9):859-64. PubMed ID: 8574718
[TBL] [Abstract][Full Text] [Related]
17. Importance of antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis and ulcerative colitis: prevalence, titre, and IgG subclass.
Bansi DS; Fleming KA; Chapman RW
Gut; 1996 Mar; 38(3):384-9. PubMed ID: 8675091
[TBL] [Abstract][Full Text] [Related]
18. Neutrophil cytoplasmic autoantibodies after liver transplantation in patients with primary sclerosing cholangitis.
Haagsma EB; Mulder AH; Gouw AS; Horst G; Meerman L; Slooff MJ; Kallenberg CG
J Hepatol; 1993 Aug; 19(1):8-14. PubMed ID: 8301047
[TBL] [Abstract][Full Text] [Related]
19. Antineutrophil nuclear antibodies (ANNA) in primary biliary cirrhosis: their prevalence and antigen specificity.
Orth T; Gerken G; Meyer Zum Büschenfelde KH; Mayet WJ
Z Gastroenterol; 1997 Feb; 35(2):113-21. PubMed ID: 9066101
[TBL] [Abstract][Full Text] [Related]
20. Anti-neutrophil antibodies in inflammatory bowel disease: prevalence and diagnostic role.
Cambridge G; Rampton DS; Stevens TR; McCarthy DA; Kamm M; Leaker B
Gut; 1992 May; 33(5):668-74. PubMed ID: 1612485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]